News & Events
21 December 2020
We are very happy to announce that patient recruitment for the EFFECT trial is progressing! Most sites were able to take measures to deal with the COVID-19 related restrictions and recruitment has been restarted. Off course, challenges remain but we are grateful that we can offer a place to most women now who are willing to join.
Due to the COVID-19 pandemic, the patient recruitment for the EFFECT trial has been put on hold. All patients who were already included stopped exercising at a physiotherapy centre and will continue when they are allowed to. In the meantime, patients will perform home-based exercise.
This time, the consortium meeting took place at the Medical University of Gdańsk in Poland.
The consortium met at the German Sport University Cologne to prepare the EFFECT and PERSPECTIVE studies.
PREFERABLE researchers Dr. Anne May (UMCU) and Prof. Dr. Karen Steindorf (DKFZ) have been invited by consortium member EUROPA DONNA – The European Breast Cancer Coalition to present at their 2nd MBC advocacy conference in Milan, Italy.

Our condolences to @europadonna, Karen Benn’s family and friends. We will miss our patient advocate who advised us so wisely on our project.

Recruitment of the #effectstudy is currently on hold due to #COVIDー19. Participants allocated to the exercise group continued exercising at home. They enjoy it very much and they exercise at the same intensity as during supervision. #h2020 #preferablembc

PREFERABLE had its 3rd consortium meeting in Gdansk, PL. We made some last preparations for the EFFECT trial to start recruitment in all centers and also had successful interactive sessions for the PERSPECTIVE study. #ExerciseOncology @EUScienceInnov @EU_H2020

Happy to announce that we started recruitment in the PREFERABLE EFFECT RCT this months. The first patient has been included last week. Thanks to Ohr oncologists and nurses for informing patients and patients for participating . #preferable_mbc #ExerciseOncology #H2020

Load More...